Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Cross-border payments new international distinction for CIB Offshore
- Mali strengthens its budget by 21.720 billion CFA francs
- In Japan, the Far East
- Yasmine Fouad succeeds Ibrahim Thiaw as head of the United Nations Convention to Combat Desertification
- Davos: The Fall of Klaus Schwab, or Why Trees Never Reach the Sky
- Cocoa: Ghanaian producers now earn double their Ivorian counterparts
- Algeria: BNA records a net profit of over 330 million euros in 2024
- UEMOA: Slight decrease in funding granted by the BCEAO on the money market in June 2025